Continuous subcutaneous insulin, or the insulin pump, has gained popularity and sophistication as a near-physiologic programmable method of insulin delivery that is flexible and lifestyle-friendly. The introduction of continuous monitoring with glucose sensors provides unprecedented access to, and prediction of, a patient’s blood glucose levels. Efforts are underway to integrate the two technologies, from “sensor-augmented” and “sensor-driven” pumps to a fully-automated and independent sensing-and-delivery system. Implantable pumps and an early-phase “bionic pancreas” are also in active development. Fine-tuned “pancreas replacement” promises to be one of the many avenues that offers hope for individuals suffering from diabetes. Although end...
Background: While multiple daily insulin injections remains the state-of-the-art treatment for type ...
In view of the current accelerating pace of diabetes technology development, ever smaller and more a...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
Continuous subcutaneous insulin, or the insulin pump, has gained popularity and sophistication as a ...
Technology for diabetes care has undergone major development during recent decades. These technologi...
A major new approach to the improvements of metabolic control in insulin-dependent diabetic patients...
Type 1 diabetes mellitus (T1DM) represents 5-10% of diabetes cases worldwide. The incidence of T1DM ...
Insulin delivery in a closed-loop mode has been a dream for many patients with insulin-treated diabe...
Abstract Type 1 diabetes is one of the most common endocrine problems in childhood and adolescence, ...
International audienceInsulin, a polypeptide hormone produced by the beta-cells of the pancreas, is ...
Insulin replacement therapy is integral to the management of type 1 diabetes, which is characterised...
Insulin pump development started in 1978, with the first commercially available glucose sensor marke...
International audienceAutomated insulin delivery (AID) systems, so-called closed-loop systems or art...
People with diabetes face a life-long optimization problem: to maintain strict glycemic control with...
Technological inventions are being used recently to enable the treatment of diabetes mellitus more e...
Background: While multiple daily insulin injections remains the state-of-the-art treatment for type ...
In view of the current accelerating pace of diabetes technology development, ever smaller and more a...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
Continuous subcutaneous insulin, or the insulin pump, has gained popularity and sophistication as a ...
Technology for diabetes care has undergone major development during recent decades. These technologi...
A major new approach to the improvements of metabolic control in insulin-dependent diabetic patients...
Type 1 diabetes mellitus (T1DM) represents 5-10% of diabetes cases worldwide. The incidence of T1DM ...
Insulin delivery in a closed-loop mode has been a dream for many patients with insulin-treated diabe...
Abstract Type 1 diabetes is one of the most common endocrine problems in childhood and adolescence, ...
International audienceInsulin, a polypeptide hormone produced by the beta-cells of the pancreas, is ...
Insulin replacement therapy is integral to the management of type 1 diabetes, which is characterised...
Insulin pump development started in 1978, with the first commercially available glucose sensor marke...
International audienceAutomated insulin delivery (AID) systems, so-called closed-loop systems or art...
People with diabetes face a life-long optimization problem: to maintain strict glycemic control with...
Technological inventions are being used recently to enable the treatment of diabetes mellitus more e...
Background: While multiple daily insulin injections remains the state-of-the-art treatment for type ...
In view of the current accelerating pace of diabetes technology development, ever smaller and more a...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...